This content is from: Features

Out of step with Europe

A review of 11 cases shows that pharmaceutical patents in Russia are being upheld despite having been invalidated in Europe. Yana Lipatova says companies should carefully review the grounds in each case

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial